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Abstract
Group A Streptococcus (GAS) has developed a broad arsenal of virulence factors that serve to circ u m v e n th o s td e f e n s em e c h a n i s m s .
The virulence factor DNase Sda1 of the hyperinvasive M1T1 GAS clone degrades DNA-based neutrophil extracellular traps allowing
GAS to escape extracellular killing. TLR9 is activated by unmethylated CpG-rich bacterial DNA and enhances innate immune
resistance. We hypothesized that Sda1 degradation of bacterial DNA could alter TLR9-mediated recognition of GAS by host innate
immune cells. We tested this hypothesis using a dual approach: loss and gain of function of DNase in isogenic GAS strains and
presence and absence of TLR9 in the host. Either DNA degradation by Sda1 or host deficiency of TLR9 prevented GAS induced IFN-a
and TNF-a secretion from murine macrophages and contributed to bacterial survival. Similarly, in a murine necrotizing fasciitis
model, IFN-a and TNF-a levels were significantly decreased in wild type mice infected with GAS expressing Sda1, whereas no such
Sda1-dependent effect was seen in a TLR9-deficient background. Thus GAS Sda1 suppressed both the TLR9-mediated innate
immune response and macrophage bactericidal activity. Our results demonstrate a novel mechanism of bacterial innate immune
evasion based on autodegradation of CpG-rich DNA by a bacterial DNase.
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Introduction
The Gram-positive bacterium Group A Streptococcus (GAS) is a
leading human pathogen, annually causing over 700 million cases of
superficial infections such as pharyngitis or pyoderma, and more than
650,000 cases of invasive infections, including the potentially lethal
conditions of necrotizing fasciitis (NF) and streptococcal toxic shock
syndrome (STSS) [1]. Increased reports of severe GAS disease in
recent decades have been in large part attributable to the emergence
of a globally disseminated clone of the M1T1 serotype [2]. M1T1
strains are the most common cause of GAS pharyngitis and are
strongly overrepresented in severe cases such as NF and STSS [3].
The ability of invasive GAS to produce life-threatening infections
even in previously healthy individuals reflects a diverse array of
virulence factors that together allow the bacterium to invade host
cellular barriers and resist innate immune clearance [2,4]. One
important distinguishing feature of the globally-disseminated M1T1
GAS clone compared to less pathogenic GAS strainsis the acquisition
of a prophage encoding a potent secreted DNase, Sda1 [5]. Sda1
activity has been shown to promote GAS escape from phagocytic
killing with DNA-based neutrophil extracellular traps (NETs) [6,7,8],
frameworks of DNA containing antimicrobial peptides, histones and
proteases that are generated by neutrophils to capture and eliminate
bacteria at tissue foci of infection [9].
To control an infection quickly and to prevent disease
progression, timely and accurate recognition of bacteria by the
host innate immune system is crucial. Pattern recognition receptors
(PRRs) such as Toll like receptors (TLRs) recognize conserved
molecular patterns from pathogens. The Toll-like receptor 9
(TLR9) is located intracellularly and recognizes unmethylated
CpG-rich DNA motifs commonly present in microorganisms but
absent in the host genome [10]. Due to its intracellular localization,
TLR9 was first appreciated to respond to intracellular pathogens
such as Listeria monocytogenes and Legionella pneumophila [11,12].
However, TLR9 has recently been shown to enhance resistance
against the common Gram-positive bacteria Streptococcus pneumoniae
[13] and GAS [14]. Following this lead, we hypothesized that the
presence of the potent DNase Sda1 in the hyperinvasive M1T1
GAS clone could modify its own unmethylated extracellular CpG-
rich DNA fragments and alter TLR9-mediated recognition by host
innate immune cells. Combining studies with M1T1 GAS and an
isogenic strain with loss of Sda1 expression with macrophages
derived from WT and TLR-9 deficient mice, we demonstrate a
novel mechanism of bacterial innate immune evasion based on
autodegradation of a key pattern-recognition molecule.
Results/Discussion
GAS genomic DNA results in IFN-a and TNF-a secretion
by murine macrophages in a dose and time dependent
manner
DNA was purified from GAS strain 5448, representative of the
globally disseminated hyperinvasive M1T1 clone, and incubated
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Cytokine release into the medium was used as readout for BMDM
activation. GAS DNA induced time-dependent release of inter-
feron type 1 (IFN-1), and specifically interferon-a (IFN-a), from
the macrophages (Fig. 1A, B), peaking at 12 h of exposure. GAS
DNA also induced BMDM TNF-a secretion, with maximal levels
already detected after 6 h of incubation and remaining elevated
for at least 24 h (Fig. 1C). Induction of IFN-a and TNF-a release
by GAS DNA was also dose-dependent (Fig. 1D). In contrast,
human DNA did not induce IFN-1 or TNF-a secretion from
BMDMs (Fig. 1A–C). We did not detect specific induction of the
cytokines IL-6, IL-1b, IL-10 or MIP-2 from BMDMs exposed to
GAS DNA (data not shown).
Unmethylated CpG-rich DNA motifs have previously been
reported to induce macrophage secretion of proinflammatory
cytokines including TNF-a and IFN-1 [10,15]. Further studies
have shown that macrophages exposed to live GAS, DNA isolated
from GAS or antibiotic-killed group B Streptococcus release IFN-b
and TNF-a [16,17]. However, bacterial DNA has not previously
been shown to stimulate IFN-a secretion, a finding relevant to
innate immune defense since IFN-a is known to provide protection
against Gram-positive bacterial infections [18].
Stimulation and secretion of IFN-a and TNF-a in murine
macrophages is TLR9 dependent
The experiments above showed that GAS DNA, containing
unmethylated CpG motifs, but not human DNA, induced IFN-a and
TNF-a release by BMDM. Since IFN type 1 secretion is partially
mediated by TLR9 [19], we tested whether cytokine release in
murine BMDMs expressing TLR9 [20,21,22], occurred in a TLR9-
dependent manner. Chloroquine blocks endosomal acidification and
is a known inhibitor of TLR9 [23,24]. We observed a significant
decrease of IFN-a and TNF-a secretion in response to GAS DNA
and to the TLR9 agonist ODN2395 in BMDMs pretreated with
chloroquine, whereas TLR4-mediated responses to LPS were
unaffected (Fig. 2A). Similar results were obtained with the synthetic
TLR9 antagonist G-ODN (Fig. 2B). To further corroborate the
TLR9 dependency, experiments were repeated with BMDMs
extracted from TLR9-deficient mice. Stimulation using the TLR9
agonist ODN2395 induced BMDM secretion of IFN-a and TNF-a
only in the presence of a functional TLR9 pathway, whereas
responses to LPS were not influenced (Fig. 2C). Similarly, after
stimulation with GAS DNA, a significantly lower release of IFN-a
and TNF-a was observed from TLR9-deficient compared to WT
BMDMs (Fig. 2C). The stimulation of IFN-a secretion from TLR9-
deficient BMDMs, albeit at a reduced level, is most likely explained
by a ubiquitous interferon response to immunostimmulatory nucleic
acids, mediated by cytosolic DNA sensors amongst others [25].
Similarly, recent work shows that IFN-b is secreted after challenge of
TLR9-deficient macrophages with live GAS or GAS DNA
complexed with RNA [16].
M1T1 GAS DNase Sda1 diminishes TLR9-dependent IFN-a
and TNF-a secretion by macrophages
An important characteristic of the hypervirulent globally dissem-
inated M1T1 clone of GAS is the presence of a prophage-encoded
secreted DNase, sda1 [5]. Sda1 has been shown to promote M1T1
GAS virulence via degradation of NETs, allowing the bacteria to
escape neutrophil killing and the tissue focus of infection, thus
facilitating systemic spread of the pathogen [2,6,7]. Functional TLR9
is important in defense against GAS infection [14] and the DNA size
required for optimal stimulation varies among host cells. Whereas B-
cellsarestimulatedbysmallDNAfragments[26],macrophagesshow
enhanced uptake and subsequent responses with increasing DNA
length [26]. Having observed efficient BMDM activation by crude
GAS DNA (above) we hypothesized that degradation by Sda1 could
reduce stimulation of macrophage and thus be an additional immune
evasion function of Sda1. To test this, we engineered recombinant
GAS Sda1 (rSda1) in E. coli. Purification yielded a 45 kD
recombinant protein which showed DNase activity at the expected
size when analyzed by zymography (Fig. 3A). Recombinant Sda1
degraded GAS DNA in a time and concentration dependent manner
(Fig. 3B–C). Recombinant Sda1 at around 4 mg/mL was similarly
efficient in degrading DNA as the natively or overexpressed Sda1 in
GAS supernatants (Fig. 3C). Degradation of GAS DNA by Sda1
abolished induction of TNF-a and IFN-a in BMDM’s (Fig. 3D).
DNase Sda1 on its own did not influence cytokine secretion (Fig. S2).
Similarly DNase Sda1 treatment of GAS DNA did not affect the
residual level of IFN-a and TNF-a induction when TLR9-deficient
BMDMs were studied (Fig. 4A). We speculate that the decreased
TLR9-dependent cytokine responses to Sda1-treated GAS DNA was
mainly due to decreased average DNA size (Fig. 3B), which has also
been shown by others to be crucial for cellular uptake of DNA and
subsequent TLR9 stimulation [26]. In addition direct elimination of
CpG motifs by the efficient enzymatic action of the bacterial DNase
[10] could potentially further contribute to the differences observed.
Since it has been reported that Sda1 can degrade RNA [27] and
recent work shows that IFN-b is secreted by macrophages after
challenge of GAS DNA complexed with RNA [16] we investigated
the action of Sda1 against RNA, in addition to DNA, wondering if
this could be a two-pronged approach to promote GAS infection.
RNA co-incubated with our rSda1 showed no degradation when
visualized by agarose gel electrophoresis (Fig. S1), suggesting that
Sda1 possesses negligibleor minor RNA-degrading activity under our
assay conditions. To study the influence of Sda1 on TLR9-mediated
macrophage responses to live GAS infection, BMDMs were
challenged with the wild type M1TI GAS parent strain M1 5448
(M1WT), the isogenic GAS DNase sda1 knockout (M1Dsda1)a n dt h e
sda1 complemented strain (M1Dsda1pDcsda1)u s i n gt h ep D c sda1
plasmid [6]. A significant increase in IFN-a and TNF-a secretion was
observed from WT BMDMs challenged with the M1Dsda1 mutant
strain compared to the parent and complemented strains (Fig. 4B).
The observed Sda1-dependent reduction of cytokine responses to
GAS was diminished in TLR9-deficient macrophages (Fig. 4B).
Author Summary
Group A Streptococcus (GAS) ranks among the top ten
human pathogens causing fatal disease. GAS possesses an
arsenal of virulence factors that circumvent the primary
mammalian defence strategies, the innate immune system.
Toll-like receptors (TLRs), allow the host to detect
pathogens by recognizing structures or patterns abundant
in pathogens but lacking in the mammalian host, including
unmethylated CpG-rich bacterial DNA recognized by TLR9.
Here we show that GAS DNA but not host DNA triggers
TNF-a and interferon type 1 cytokine secretion by
monocytic cells, and that this secretion is dependent on
the presence of functional TLR9. The highly virulent M1T1
GAS clone expresses the virulence factor DNase Sda1.
Sda1-mediated bacterial DNA degradation was shown to
prevent TLR9-dependent cytokine release in monocytes,
which then fail to effectively phagocytose and kill bacteria.
In a mouse necrotizing fasciitis model, the streptococcal
DNase Sda1 suppressed TLR9-dependent INF-a and TNF-a
induction. Inhibition of TLR9 recognition by a bacterial
DNase thus illustrates a novel mechanism of microbial
innate immune evasion.
Group A Streptococcal DNase and TLR9 Recognition
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strain diminished BMDM IFN-a and TNF-a secretion in a TLR9-
dependent manner (Fig. 4C) .O u rp a i r e dl o s s -a n dg a i n - o f - f u n c t i o n
analyses indicate that Sda1 is both necessary and sufficient to
promote GAS avoidance of TLR9-dependent macrophage recogni-
tion [10].
TLR9 is activated by CpG-rich DNA motifs present in most
bacteria. Evolution of reduced CpG content (CpG suppression)
has been described in other microorganisms including nonpatho-
genic viruses, Plasmodium falciparum and Entamoeba histolytica [28]. In
contrast GAS DNA possesses a high CpG content. By acquiring a
potent secreted DNA-degrading enzyme, GAS has come across an
alternative means to circumvent TLR9 activation in the host
innate immune response.
GAS DNase Sda1 promotes resistance to macrophage
intracellular killing
To date, DNase Sda1 has been appreciated to promote M1T1
GAS resistance to neutrophil extracellular killing due to its
capacity to digest NETs [6,7,8]. Since we here identified a
capacity of Sda1 to diminish TLR9-mediated macrophage
responses, we hypothesized that the DNase activity could blunt
the innate immune killing capacity of macrophages to kill GAS.
Mice depleted of macrophages or treated with inhibitors of
macrophage phagocytosis cannot clear GAS infections even at
relatively low challenge doses [29], demonstrating the essential first
line defense function of these immune cells against the pathogen.
WT and TLR9-deficient BMDMs were challenged with live M1
or M49 GAS either expressing or not DNase and total, intra and
extracellular bacterial killing was quantified. GAS strains express-
ing Sda1 survived significantly better in both the total and
intracellular killing assays compared to the strains in which Sda1
was not expressed (Fig. 5A, B and S3). The Sda1-mediated
survival advantages for GAS were much more pronounced in WT
compared to TLR9-deficient BMDMs.
Sda1-mediated resistance to total macrophage killing could be
caused by interference with DNA-based extracellular traps, which,
we have recently observed, are generated by macrophages [30]
though to a much lesser extent than observed in neutrophils or
Figure 1. Stimulation of murine macrophages by human and GAS DNA. (A–C) Bone marrow-derived mice macrophages (BMDMs) were
stimulated with GAS and human genomic DNA (both 5 mg/ml) and secretion of IFN1, IFN-a and TNF-a in the supernatants measured. (D) Dose-
dependency of GAS DNA-mediated stimulation (12 hours) of IFN-a and TNF-a secretion. Data were pooled from 3 experiments done in triplicates and
presented as mean 6 SEM. * P,0.05 ** P,0.01.
doi:10.1371/journal.ppat.1002736.g001
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PLoS Pathogens | www.plospathogens.org 3 June 2012 | Volume 8 | Issue 6 | e1002736Figure 2. GAS DNA stimulation of murine macrophages is TLR9-dependent. (A, B and C) To test for TLR9-dependency of GAS DNA-
mediated BMDMs stimulation, the known inhibitors of the TLR9 pathway cloroquine (100 mM) and G-ODN (10 mM) as well as the stimulator ODN2395
(1 mM) were used together with BMDMs derived from wild type and TLR9-deficient mice. LPS (10 ng/ml) was used as a positive control in experiments
with perturbed TLR9 signalling. The addition of chloroquine or G-ODN and the use of TLR9-deficient BMDMs significantly reduced the GAS DNA and
ODN2395-mediated production of IFN-a and TNF-a while stimulation mediated by LPS was unaffected. Data were pooled from 3 experiments done in
triplicate and presented as mean 6 SEM. *P,0.05 ** P,0.01 *** P,0.001.
doi:10.1371/journal.ppat.1002736.g002
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Sda1 interferes with extracellular killing by macrophages we
pretreated the macrophages with cytochalasin D to inhibit
phagocytosis. No difference between GAS WT and the isogenic
GAS DNase sda1 knockout strains were observed for the
extracellular killing indicating that the Sda1-dependent survival
advantage seen in vitro is indeed mainly intracellular (Fig. S4). To
further explore the Sda1-dependent survival advantage of GAS
intracellularly following phagocytotic uptake into the macrophag-
es, we measured oxidative burst activity, which has been reported
to be a TLR9-induced mediator of intracellular killing in murine
macrophages [14]. Oxidative burst activity was measured in WT
and TLR9-deficient BMDMs after infection with the isogenic
pairs of GAS strains either expressing or lacking DNase Sda1.
BMDMs infected with GAS strains possessing Sda1 displayed a
significantly reduced oxidative burst response compared to
BMDMs infected with GAS strains lacking Sda1 (Fig. 5C). We
propose that reduced oxidative burst is an additional mechanism
by which Sda1 can contribute to M1T1 GAS resistance to
macrophage killing. In order to test if blocking IFN-a and TNF-a
can prevent phagocytic killing mediated by GASDsda1 we
repeated the BMDM killing assays with WT BMDM challenged
with WT GAS M1 and GASDsda1 bacteria after having pre-
incubated the BMDM with either the neutralizing antibodies
against TNF-a or IFN-a or their respective controls. Addition of
neutralizing IFN-a antibodies increased the survival of GAS and
Figure 3. The recombinant GAS DNase Sda1 degrades genomic DNA. (A) Zymogram and (B and C) agarose gel electrophoresis were used to
visualize degradation of DNA by rSda1. (B) The size of the GAS DNA treated with rSda1 for 0 to 6 hours was analyzed by agarose gel electrophoresis.
(C) Supernatants of the GAS strains used in the assays were co-incubated with DNA. DNA degradation was assessed by agarose gel electrophoresis:
the degradation efficiency displayed by GAS supernatants was directly compared to the degradation efficiency of different concentrations of rSda1.
(D) GAS DNA was pre-incubated with rSda1 for 0 to 6 hours before the reaction mixture was tested for its capacity to induce cytokine secretion in
BMDMs. The data were pooled from 3 experiments done in triplicates and presented as mean 6 SEM., *P,0.05, **P,0.01 as compared to the 0 hour
time point.
doi:10.1371/journal.ppat.1002736.g003
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PLoS Pathogens | www.plospathogens.org 5 June 2012 | Volume 8 | Issue 6 | e1002736Figure 4. The GAS DNase Sda1 interferes with TLR9 activation. (A) IFN-a and TNF-a secretion by BMDMs after GAS DNA challenge for
12 hours was almost abolished after adding recombinant Sda1 to GAS DNA. (B and C) Stimulation of BMDMs by GAS strains expressing Sda1 (GASM1
WT and GASM49 pDcsda1) for 12 hours secreted significantly less IFN-a and TNF-a compared to matching strains lacking Sda1 (GASM1 Dsda1 and
GASM49 WT pDcerm). Data were pooled from 3 experiments done in triplicates and presented as mean 6 SEM. ** P,0.01 *** P,0.001.
doi:10.1371/journal.ppat.1002736.g004
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PLoS Pathogens | www.plospathogens.org 6 June 2012 | Volume 8 | Issue 6 | e1002736Figure 5. GAS DNase Sda1 promotes resistance to macrophage killing. (A and B) BMDMs were inoculated at an MOI=1 with GAS M1 and
M49 strains expressing or lacking Sda1. A significantly higher survival rate, for both total (A) and in intracellular killing (B), was seen for GAS strains
expressing Sda1. Differences in killing could not be observed in BMDMs derived from TLR9-deficient mice. (C) Oxidative burst of WT and TLR9-
deficient BMDMs was measured as fluorescent units at 535 nm after 30 min stimulation with GAS M1 or GAS M49 strain either expressing or lacking
Sda1. The oxidative burst fluorescent units of the non-stimulated control macrophages were set at 1. The presence of Sda1 decreased oxidative burst
in WT BMDMs while no effect was detected in TLR9-deficient BMDMs. Data used in Fig. 5A and B were pooled from 3 experiments done in triplicate.
Data shown in Fig. 5C is one out of three representative experiments each done in triplicate and presented as mean 6 SEM (A and B) 6 SD (C).
* P,0.05 ** P,0.01.
doi:10.1371/journal.ppat.1002736.g005
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effect of neutralizing TNF-a antibodies was smaller and not
statistically significant upon challenge with WT GAS and
GASDsda1 mutant bacteria (Fig. S7). These results suggest that
certain cytokines may themselves contribute to enhance the
phagocytic killing of bacteria.
Viability of the BMDMs was .90% after 4 and 12 h of
stimulation with the bacteria at MOI of 1. No significant
differences were observed in survival of WT or TLR9 deficient
BMDMs stimulated with either GAS WT or the GASDsda1
mutant (Fig. S6).
All GAS strains are known to express DNase activity, and some
strains produce up to 4 different DNases. As first described by
Wannemaker [27,31] these proteins were designated DNase A, B,
C and D. However the role of theses DNases remained unclear
until 50 years later when it was shown that GAS DNase activity,
particularly that of GAS DNase D (now known as Sda1) was
important for virulence [6,8]. By creating knockout mutants of the
three DNases present in the GAS MGAS5005 strain [8], Sumby et
al. determined that Sda1 was the most active. Sda1 very efficiently
degraded DNA in vitro. In murine skin infection models,
engineered GAS strains expressing Sda1 alone were found to be
as virulent as wild-type GAS, supporting the conclusion that Sda1
but no other DNases mediate virulence in vivo. The strong activity
of Sda1 compared to the weaker DNA-degrading activity of the
other DNases found in GAS, may help to explain the pronounced
phenotype we have observed in enhancing TLR9-mediated
clearance when only Sda1, and no other DNases, is knocked
out. However our data may underestimate the full collective
potential of GAS DNases in TLR9-mediated innate immune
evasion.
The GAS DNase Sda1 diminishes local secretion of IFN-a
and TNF-a in a mouse necrotizing fasciitis skin infection
model
To provide in vivo corroboration of the ex vivo experiments
carried out using BMDMs, we examined IFN-a and TNF-a levels
in skin homogenates of mice infected subcutaneously with GAS.
Despite the important contribution of Sda1 to GAS proliferation
and necrotic ulcer development in this model [6,7], WT mice
infected with the GAS M1Dsda1 mutant showed higher levels of
IFN-a and TNF-a in the skin samples than mice infected with the
WT parent GAS expressing Sda1 (Fig. 6A, B). Parallel
experiments performed in TLR9-deficient mice showed much
lower cytokine levels in the infected skin compared to WT mice,
again underlining the importance of TLR9 in mediating cytokine
responses. However, in contrast to the WT mice, the presence or
absence of Sda1 did not affect the level of cytokines produced in
response to GAS in the TLR9-deficient mice (Fig. 6A, B). We had
shown previously [14] that more bacteria are found in the skin of
TLR9-deficient mice compared to WT mice, and that more
surviving GASM1 WT bacteria compared to GASM1Dsda1 are
present following experimental challenge of WT mice [6]. We also
found more WT than DSda1 mutant bacteria present following
injection into TLR9- deficient mice (Fig. S8). The observation
that the TLR9-deficient mice injected with the GASM1Dsda1
mutant demonstrated similar bacterial counts compared to WT
mice could be due to a large initial influx of neutrophils efficiently
clearing the DNase-deficient mutant strain within extracellular
traps. The increased cytokine levels detected in WT mice injected
with GASM1Dsda1 mutant compared to WT bacteria are not
explained by differences in bacterial counts, nor do bacterial levels
account for increased cytokine levels in WT mice compared to
TLR9- deficient mice. In sum, we documented that increased
tissue expression of IFN-a and TNF-a in the mouse necrotizing
skin infection model occurred in both a DNase- and TLR9-
dependent manner.
In contrast to our ex vivo data and tissue culture experiments
carried out by others [25], IFN-a and TNF-a secretion in our in
vivo experiments was strictly TLR9-dependent. This finding
suggests that TLR9 recognition of GAS is of true physiological
relevance, and the described TLR9-independent pathways elicited
ex vivo may be of diminished importance in the in vivo setting. Our
experiments emphasize the critical nature of innate immune
recognition at tissue foci of infection. It is important to note that
while much evidence exists that IFN-a is beneficial to innate
immune cells in combating bacterial infection [18], if IFN-a is
produced systemically at high levels or in an uncontrolled fashion
and deleterious effects on antibacterial clearance may be observed
[32].
In our work we have focused on the cytokine responses and
killing activities of isolated macrophages vs. GAS and the
expression of cytokines at the site of GAS subcutaneous infection.
We hypothesize that GAS Sda1 contributes to disease in multiple
ways, including interfering with TLR9 recognition (blunting the
initial innate immune response) and degrading extracellular traps
(promoting phagocyte evasion). Together, these Sda1-dependent
virulence phenotypes increase the risk of bacterial proliferation to
produce severe necrotizing infections, septicemia or toxic shock
syndrome, where ultimately high cytokine levels develop in
response to the uncontrolled infection [33]. Additionally, variation
in cytokine responses to GAS superantigens influences the severity
of streptococcal toxic shock syndrome [34].
To summarize, we here describe a novel mechanism by which a
bacterial pathogen can directly elude TLR9 recognition. The GAS
virulence factor DNase Sda1 leads to decreased production of the
proinflammatory cytokines IFN-a and TNF-a and to decreased
killing efficiency of macrophages, which are key contributors for
innate immunity to GAS infection [29]. DNase production is now
recognized to be a virulence factor of a number of bacterial
pathogens including Streptococcus pneumoniae [35], Staphylococcus
aureus [36] and Pseudomonas aeruginosa [37] and it could be fruitful
to determine whether evasion of TLR9-based detection comple-
ments NET degradation in the infectious pathogenesis of these
species. Previously, inhibition of Sda1 activity by G-actin boosted
neutrophil extracellular killing of the WT GAS bacteria and
reduced lesion size in the necrotizing skin infection model,
providing proof-of-principle that this DNase can represent a
pharmacological target for virulence factor neutralization [6]. Our
current data, demonstrating that loss of Sda1 enhances both
TLR9-mediated innate immune responses and macrophage
bacterial killing, provides additional rationale toward such a
therapeutic strategy.
Materials and Methods
Mice and bacterial strains
C57BL/6 wild-type (WT) and C57BL/6 TLR9-deficient mice
were bred and handled in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was approved by
the Institutional Animal Care and Use Committee of the
University of California, San Diego (Animal Welfare Assurance
Number: A3033-01). All efforts were made to minimize suffering
of animals employed in this study.
C57BL/6 TLR9-deficient mice were originally developed by
Dr. Shizuo Akira (Osaka University, Japan); WT mice were
purchased from Charles River Laboratories. The GAS strain
Group A Streptococcal DNase and TLR9 Recognition
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with necrotizing fasciitis and toxic shock syndrome [38] and the
GAS M49 strain NZ131 [39] were used. In addition, to analyze
gain and loss of function of Sda1, GAS strains expressing Sda1
(GASM1T1 WT, GASM1T1 Dsda1pDcsda1 and GASM49
pDcsda1) and lacking Sda1 (GASM1T1 Dsda1 and GASM49
WT pDcerm) were used in the assays as described previously [6,40]
Growth curves showed that all strains used in the experiments
grew identically. GAS strains were propagated in Todd-Hewitt
broth (THB) (Difco, BD Diagnostics) or Todd-Hewitt agar plates.
For use in macrophages and mouse challenge studies, bacteria
were grown to logarithmic phase in THB (OD600=0.4 corre-
sponding to ,2610
8 cfu/ml), pelleted, washed and resuspended
in PBS or tissue culture media at the desired concentration.
GAS and human genomic DNA preparation
GAS genomic DNA was prepared using Bactozol kit (Molecular
Research Center Inc.) with minor modifications. GAS strains were
incubated overnight in THB medium, 2 ml of the overnight
culture pelleted and resuspended in Bactozol buffer+50 U
mutanolysin and 10 U Proteinase K, then incubated at 45uC for
90 min. Bactozol enzyme was added and the preparation
incubated for 60 min at 45uC. From this step on, the standard
Bactozol kit protocol was followed. Human genomic DNA was
prepared from buffy coats of healthy volunteers from the blood
donation center in Zurich, Switzerland. Cells were pelleted by
centrifugation at 1000 g for 10 min. Genomic DNA was then
extracted using blood and tissue DNA easy kit (Qiagen) following
the manufacturer’s protocol. Remaining RNA was digested by
adding RNase during DNA purification. Purity of the isolated
DNA, bacterial or human, was confirmed by lack of any cytokine
stimulation after digesting the DNA with DNase I (Roche) (Fig.
S5). Genomic DNA integrity was confirmed by agarose gel.
Sda1 production and purification
The sda1 gene was amplified from GAS M1T1 genomic DNA
using primers forward 59-TCGAGCTCTCTAAACATTGGA-
GACATCTAATTATTCACTCTG-39 and reverse 59-TGGTCG-
ACTTATTCTATATTTTCTTGAGTTGAATGATG-39. The
PCR product was subcloned into vector pQE30 and the newly
created plasmid transformed into the E. coli strain M15-pREP4
(Qiagen) for protein production. Bacteria were grown to
OD600=0.5 at 30uC in the presence of 100 mg/ml ampicillin
and 25 mg/ml kanamycin and the expression of Sda1 induced for
1 h via addition of 1 M IPTG. Bacteria were then harvested,
resuspended in 30 ml lysis buffer (50 mM NaH2PO4, 300 mM
NaCl, 20 mM imidazole pH 8) and lysed by sonication at full
power (20 cycles of 15 seconds each). Cell debris were spun down
at 12,000 g for 30 min, the supernatant filtered through a 0.45 mm
PVDF filter, then run on a HiTrap nickel bead column (GE
Healthcare) at a 1 ml/min speed. The column was then washed
with 10 volumes lysis buffer and with 10 volumes wash buffer
(50 mM NaH2PO4, 300 mM NaCl, 50 mM imidazole pH 8).
Sda1 was eluted with 5 ml elution buffer (50 mM NaH2PO4,
300 mM NaCl, 250 mM imidazole pH 8), dialysed against storage
buffer (50% glycerol in PBS) and stored at 220uC.
Zymogram
The quality and activity of the purified recombinant Sda1 were
checked by performing a zymogram. Briefly, 1 mg of Sda1 and
1 mg of DNaseI, used as a control for activity, were loaded on a
12% polyacrylamide gel containing 10 mg/ml of calf thymus
DNA. The gel was washed 2 times in ddH2O and then incubated
overnight in 50 mM TRIS?HCl pH 7.4. The gel was then
incubated (35 hours, 37uC) in Sda1 reaction buffer (50 mM
TRIS?HCl pH 7.4, 5 mM CaCl2) containing 1 mg/ml EtBr. DNA
degradation showed on gel as a dark band and was taken as a
proof of nuclease activity.
Pretreatment of genomic bacterial DNA with nucleases
Genomic DNA (2.5 mg) was incubated with DNase I from
bovine pancreas (Roche) at 37uC for 6 hours. Furthermore, 2.5 mg
of genomic DNA were incubated with purified recombinant Sda1
Figure 6. GAS DNase Sda1 diminishes local secretion of IFN-a and TNF-a in a mouse necrotizing fasciitis model. (A and B) IFN-a and
TNF-a concentrations were measured by ELISA in skin homogenates of mice infected with WT GASM1 or Dsda1 mutant strains 4 days previously.
Samples derived from WT mice infected with GASM1 WT contained significantly lower levels of IFN-a and TNF-a compared to the samples derived
from WT mice infected with GASM1 Dsda1. Low levels of IFN-a and TNF-a were detected in TLR-9 mice irrespective of the presence of Sda1. Data are
displayed as box blots with n=5 for the group of TLR9 mice injected with GAS Dsda1 and n=6 for the other groups. Box and whiskers plot, box
containing 50% with median, whiskers 2.5–97.5%. The data shown are pooled from two independent experiments. In (A) ANOVA was significant at
*P,0.05, with the group of WT mice infected with GASM1 Dsda1 having stronger IFN-a induction (Bonferroni comparison). In (B) a factorial analysis
revealed that both the mouse (P,0.01) and bacteria strain (P,0.02) as significant factors with significant interaction (P,0.01).
doi:10.1371/journal.ppat.1002736.g006
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was added to stop the reaction and the samples were loaded on an
agarose gel or added to the BMDMs. DNA alone and DNase
buffer without adding recombinant Sda1 served as controls.
Degradation of genomic DNA was confirmed by agarose gel
electrophoresis.
GAS DNA degradation assay by bacteria supernatants
The GAS DNase Sda1 activity was tested as previously
described with minor modifications [6]. 5 ml of a 1:100 dilution
of filtered supernatants taken at OD600 0.4 were mixed with 3 ml
reaction buffer (50 mM Tris-HCl, 5 mM CaCl), 20 ml of water
and 2 ml of GAS genomic DNA (125 ng/ml) and incubated for five
minutes at 37uC. The reaction was stopped by addition of 1 M
EDTA. The DNA was run on 1% agarose gel for visualisation.
Mice bone marrow derived macrophages isolation
Murine bone marrow-derived macrophages (BMDMs) were
isolated as previously described [41] with some modifications.
Bone marrow cells were collected from mice legs and cultured for
7 days in Dulbecco’s modified Eagle’s medium (high glucose)
supplemented with 30% L-929 cell conditioned medium. The
adherent cells (BMDM) were then collected, split to assay settings,
and cultured in Dulbecco’s modified Eagle’s medium (high
glucose) until being used for experiments on day 10.
Macrophage challenge with genomic DNA or bacteria
BMDM (5610
5) were seeded into each well of a 48 well plate in
500 ml medium. On day 10, 2 h before the inoculation of genomic
DNA or bacteria, BMDM were washed twice with PBS, and
200 ml DMEM+10% FBS (70uC heat inactivated) were added to
each well. GAS strains and genomic DNA, prepared as described
above, were inoculated into wells at a multiplicity of infection
(MOI) of 1 and 5 mg/ml respectively. In addition 80 ml of the
DNA samples obtained after digestion with rSda1 for 0, 1, 2, 4 and
6 hours were used. Media without addition of DNA or rSda1 as
well as media containing rSda1 alone served as controls. Plates
inoculated with bacteria were centrifuged at 800 g for 10 min,
incubated at 37uCi naC O 2 incubator for 2 h, and penicillin G
and gentamicin added to each well to a concentration of 10 and
100 mg/ml, respectively. As TLR9 specific agonist and antagonist,
5 mg/ml CpG-ODN 2395 (Microsynth, 59-tcg tcg ttt tcg gcg gcg
ccg-39 with phosphorothioate on all bases) and G-ODN (Micro-
synth, 59- ctc cta ttg ggg gtt tcc tat -39 with phosphorothioate on all
bases) were used. Challenged macrophages were incubated at
37uC with 5% CO2 for 12 h. The plates were centrifuged at 800 g
for 10 min before the supernatants were taken and stored in
280uC until they were used in ELISA assays.
Cytokine measurements
IFN-a and TNF-a ELISA: Levels of IFN-a in culture
supernatants were analyzed by a standard sandwich ELISA using
a monoclonal mouse IFN-a capture antibody (Hycult biotech) and
polyclonal rabbit IFN-a antibody (PBL interferon source) together
with a goat anti-rabbit antibody conjugated with HRP (Invitro-
gen). A serial dilution of recombinant mouse IFN-a (PBL
interferon source) was used to calculate the absolute concentration
in the supernatants. Levels of TNF-a were measured using mouse
TNF-a ELISA kit (R&D) following the manufacturer’s protocol.
Interferon type 1 cell luciferase assay: Luciferase cell reporter
assay of IFN-1 was carried out using the LL171 luciferase reporter
cell line as described [42].
Macrophage killing assays and oxidative burst expression
Macrophages were harvested and seeded in 48 well plates as
described above. Two hours before adding bacteria, macrophages
were washed twice with PBS and 400 ml of DMEM+2% FBS were
added to each well. Logarithmic phase bacteria were added to the
wells at final MOI of 1 and plates were centrifuged for 5 minutes
at 1500 rpm. For total killing, the plate was incubated for 4 hours.
For intracellular killing assays, 100 mg/ml penicillin G and
100 mg/ml gentamicin were added to the wells and the plate
was incubated for another 2 h at 37uCi n5 %C O 2 before
macrophages were detached with trypsin and lysed with 0.025%
Triton-X100. Serial dilutions of the lysates were plated on THA
for enumeration of surviving bacterial colony forming units (cfu).
Reactive oxygen species were measured following the protocol
described before [14].
Murine infection model
An established murine model of necrotizing skin infection was
used [43]. Briefly, logarithmic phase GAS were resuspended in
PBS, mixed 1:1 with sterile Cytodex beads (Sigma) and an
inoculum of 5610
7 cfu of GAS was injected subcutaneously into
one flank of 10–12 week old WT or TLR9-deficient mice. At day
four the mice were euthanized and skin from the lesion was
collected, homogenized and IFN-a and TNF-a measured by
ELISA and bacterial counts assessed after serial dilutions and
plating on THA plates.
Statistics
Data were analysed and edited using the SPSS (SPSS 11.5 Inc.,
Chicago, Illinois, USA), the NCSS (Kaysville, Utah, USA) and
Graphpad prism 5 software (Graphpad Software Inc, La Jolla,
California, USA) packages. Two-sample two-tailed homoscedastic
t-tests were used to calculate the indicated p-values except for the
animal studies (Fig. 6) for which analysis of variance (ANOVA)
followed by Bonferroni comparison and a factorial analysis (2-way
ANOVA) were used to calculate indicated p-values.
Supporting Information
Figure S1 No degradation of RNA was observed by
recombinant GAS DNase Sda1. RNA was isolated from GAS
and co-incubated with either the DNase buffer alone or with
365 ng of the recombinant Sda1 in DNase buffer for 10 minutes at
37uC. Visualisation followed by 1.5% TBE agarose gel electro-
phoresis.
(TIF)
Figure S2 The recombinant GAS DNase Sda1 does not
induce IFN-a and TNF-a secretion. rSda1 was co-incubated
with murine macrophages and the cytokine response measured
after 12 hours.
(TIF)
Figure S3 The GAS DNase Sda1 interferes with TLR9
activation. Stimulation for 12 hours of BMDMs with GAS
strains expressing Sda1 (GASM1 WT and GASM1 Dsda1 pDcsda1)
resulted in significantly less IFN-a and TNF-a secretion compared
to matching strains lacking Sda1 (GASM1 Dsda1). Data were
pooled from 3 experiments done in triplicates and presented as
mean 6 SEM.
(TIFF)
Figure S4 The GAS DNase Sda1 does not affect extra-
cellular killing in macrophages.
(TIF)
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induce IFN-a and TNF-a secretion. In order to test for purity
of our isolated bacterial DNA we co-incubated the bacterial DNA
with and without DNaseI and stimulated BMDMs for 12 hours.
Addition of DNaseI resulted in similarly low IFN-a and TNF-a
secretion as observed for the controls.
(TIF)
Figure S6 BMDMs viability assays. Logarithmic phase
bacteria were added to BMDM at MOI 1. Recombinant
streptolysin O (rSLO) was used as a positive control at a final
concentration of 16 mg/ml. After 4 (A) and 12 hours (B) BMDMs
were analysed using the mammalian cell live/dead staining kit or
the MTT assay at 4 (C) and 12 hours (D) respectively. Data were
pooled from 3 experiments done in triplicates and presented as
mean 6 SEM.
(TIF)
Figure S7 Addition of neutralizing antibodies against
INF-a increases bacterial survival of GAS. In order to test if
blocking IFN-a and TNF-a can prevent phagocytic killing
mediated by GASDsda1 we repeated the BMDM killing assays
using with WT BMDM challenged with GASWT M1 and
GASDsda1 bacteria (MOI 1) after having pre-incubated the
BMDM for 2 h with either the neutralizing antibodies against
TNF-a or IFN-a or their respective controls. Data were pooled
from 3 experiments done in triplicates and presented as mean 6
SEM. ** P,0.01.
(TIF)
Figure S8 TLR9 is important for controlling GAS
infection in vivo. WT and TLR9-deficient mice were injected
subcutaneously with equivalent inocula of GASWT M1 and
GASDsda1 and after 4 days bacteria were enumerated in the skin.
N=5 for the group of TLR9 mice injected with GAS Dsda1 and
n=6 for the other groups. Data shown were pooled from two
independent experiments and presented as mean 6 SEM.
(TIF)
Text S1 Contains supplementary methods of the sup-
plemental data.
(DOC)
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